4//SEC Filing
HOWSON TAMAR D 4
Accession 0000899243-22-001050
CIK 0001645460other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:24 PM ET
Size
5.4 KB
Accession
0000899243-22-001050
Insider Transaction Report
Form 4
HOWSON TAMAR D
Director
Transactions
- Award
Stock Option (right to buy)
2022-01-03+10,000→ 10,000 totalExercise: $12.28Exp: 2032-01-02→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
- [F2]This option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001202286
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 8:24 PM ET
- Size
- 5.4 KB